Nathan Denton

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Drug Administration

Human Immunodeficiency Virus

Polycystic Ovary Syndrome

Top Venues

Orphanet journal of rare diseases

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Nathan Denton, Andrew E Mulberg, Monique Molloy, Samantha Charleston, David C Fajgenbaum, Eric D Marsh, Paul Howard
Correction to: Sharing is caring: a call for a new era of rare disease research and development. Orphanet journal of rare diseases 18 (1) (2023)
Nathan Denton, Andrew E Mulberg, Monique Molloy, Samantha Charleston, David C Fajgenbaum, Eric D Marsh, Paul Howard
Correction to: Sharing is caring: a call for a new era of rare disease research and development. Orphanet journal of rare diseases 18 (1) (2023)
Nathan Denton, Andrew E Mulberg, Monique Molloy, Samantha Charleston, David C Fajgenbaum, Eric D Marsh, Paul Howard
Correction to: Sharing is caring: a call for a new era of rare disease research and development. Orphanet journal of rare diseases 18 (1) (2023)
Nathan Denton, Andrew E Mulberg, Monique Molloy, Samantha Charleston, David C Fajgenbaum, Eric D Marsh, Paul Howard
Sharing is caring: a call for a new era of rare disease research and development. Orphanet journal of rare diseases 17 (1) (2022)
Nathan Denton, Monique Molloy, Samantha Charleston, Craig Lipset, Jonathan Hirsch, Andrew E Mulberg, Paul Howard, Eric D Marsh
Data silos are undermining drug development and failing rare disease patients. Orphanet journal of rare diseases 16 (1) (2021)
Nellie Y Loh, James E N Minchin, Katherine E Pinnick, Manu Verma, Marijana Todorčević, Nathan Denton, Julia El-Sayed Moustafa, John P Kemp, Celia L Gregson, David M Evans, Matthew J Neville, Kerrin S Small, Mark I McCarthy, Anubha Mahajan, John F Rawls, Fredrik Karpe, Constantinos Christodoulides
RSPO3 impacts body fat distribution and regulates adipose cell biology in vitro. Nature communications 11 (1) (2020)